register

News & Trends - MedTech & Diagnostics

MTAA CEO sheds light on policy and advocacy focus for 2024

Health Industry Hub | January 31, 2024 |

MedTech & Diagnostics News: In this Health Industry Hub interview, Ian Burgess, CEO of MTAA, acknowledged the top highlights that led to meaningful change in 2023, and voiced the key policy agenda for the new year.

The interview highlighted the intense consultation process surrounding the Prescribed List (PL) and private health insurance reforms, emphasising their significance for the medtech sector. Mr Burgess touched upon the potential challenges posed by an early federal election and underscored the factors that will determine success of the reforms.

Environmental sustainability emerged as a strategic focus for the medtech sector, driven by increasing pressures and interest from stakeholders such as surgeons, hospitals, and policy makers. The first National Health and Climate Strategy also aims to establish green procurement guidelines. MTAA’s role and advocacy objectives in supporting the industry through the evolving changes was highlighted.

Nurturing innovation and ensuring supply chain resilience were identified as additional priority areas for the medtech sector. Mr Burgess delved into the obstacles that still need to be overcome to make progress in these areas.

Looking ahead, the interview explored the main complexities and uncertainties expected to impact the medtech sector this year. Mr Burgess outlined how these challenges correlate with MTAA’s policy and advocacy plans, providing insights into the industry body’s strategic approach to addressing the evolving landscape of the medtech industry in 2024.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. To subscribe, please click here and visit T&Cs here.


News & Trends - MedTech & Diagnostics

Aussie medtech forges ahead, making inroads with new technology

Aussie medtech forges ahead, making inroads with new technology

Health Industry Hub | February 23, 2024 |

MedTech & Diagnostics News: Adelaide-based medical technology firm, LBT Innovations has successfully delivered its cutting-edge Automated Plate Assessment System (APAS) […]

More


News & Trends - Pharmaceuticals

Is the imposed PBS funding cap driving the migraine medicines shortage?

Is the imposed PBS funding cap driving the migraine medicines shortage?

Health Industry Hub | February 23, 2024 |

Pharma News: Australia finds itself grappling with an unparalleled shortage of migraine prevention medicines, leaving a significant impact on the […]

More


News & Trends - Pharmaceuticals

MSAC rejects Janssen's CAR T therapy despite clinical superiority, citing need for 'substantial price reduction'

MSAC rejects Janssen’s CAR T therapy despite clinical superiority, citing need for ‘substantial price reduction’

Health Industry Hub | February 23, 2024 |

Pharma News: The Medical Services Advisory Committee (MSAC) has deferred its decision on whether Janssen’s CAR T-cell therapy Carvykti (cilta-cel) […]

More


News & Trends - Pharmaceuticals

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Health Industry Hub | February 23, 2024 |

Pharma News: The Therapeutic Goods Administration (TGA) has granted approval for the first endometriosis treatment in 13 years. Gedeon Richter […]

More


This content is copyright protected. Please subscribe to gain access.